Table 1.
Baseline characteristics of the subjects
| Placebo (n = 5) | GH (n = 5) | T (n = 6) | GHT (n = 5) | All (n = 21) | P value | |
|---|---|---|---|---|---|---|
| Age (yr) | 69.8 (1.5) | 70.6 (1.3) | 70.3 (0.9) | 70.4 (1.8) | 70.2 (0.6) | 0.98 |
| Weight (kg) | 77.2 (5.6) | 78.3 (4.3) | 77.2 (3.8) | 83.9 (5.3) | 80 (2.3) | 0.68 |
| Body mass index (kg/m2) | 24.8 (1) | 26.3 (1.3) | 26.1 (0.9) | 27.5 (1.6) | 26.1 (0.5) | 0.54 |
| Waist to hip ratio | 0.95 (0.01) | 0.95 (0.01) | 0.9 (0.01) | 0.94 (0.02) | 0.93 (0.009) | 0.16 |
| IGF-I (ng/ml) | 103.8 (6.9) | 104.5 (12.9) | 118.3 (12.9) | 109.1 (11.4) | 109.1 (5.3) | 0.80 |
| T (ng/dl) | 507.2 (80.6) | 440.9 (63.4) | 495.6 (63.4) | 512.9 (83.5) | 489.9 (33.4) | 0.88 |
| FT index | 0.22 (0.04) | 0.14 (0.01) | 0.18 (0.03) | 0.14 (0.02) | 0.17 (0.01) | 0.18 |
| FT pg/ml | 121 (18) | 110 (16.4) | 121 (14.6) | 125 (22.1) | 119 (8.3) | 0.94 |
All values are presented as mean (se). The P value is for the overall comparison between groups. To convert T to nmol/liter, multiply values by 0.0347. To convert IGF-I to nmol/liter, multiply by 0.131.